Company leverages aircraft to merge business activity with corporate citizenship
Submitted by: Dow Chemical Company
Posted: Nov 05, 2012 – 08:00 AM EST
MIDLAND, Mich., Nov. 05 /CSRwire/ - The Corporate Angel Network (CAN), a charitable organization dedicated to helping cancer patients and their care givers access the best possible treatment, has recognized The Dow Chemical Company (NYSE: DOW) with its “Angel of the Year” award for the Company’s outstanding service to cancer patients.
Dow has partnered with CAN for nearly 30 years, flying more than 6,000 flights that have helped patients with catastrophic illness and costly medical bills reach the specific treatment center needed for their particular type of cancer. Dow employees and retirees also utilize the program, some of them making weekly commutes for treatment.
“I am honored and humbled to accept such an award on behalf of Dow,” said Gregory Freiwald, Chief Human Resources Officer, Aviation, Corporate Affairs, and Executive Vice President, who accepted the award October 31 during the National Business Aviation Association’s 65th Annual Meeting and Convention. “This is a testament to how deeply corporate citizenship is ingrained in everything we do – both in seeking new opportunities to solve world challenges, and to leveraging our day-to-day operations into partnerships that improve the human condition.” Eugene Cernan, retired U.S. Navy officer, former NASA astronaut and the last man to walk on the moon, presented the award.
CAN is the only charitable organization in the U.S. whose sole mission is to help cancer patients access the best possible treatment for their specific type of cancer by arranging free travel to treatment across the country using empty seats on corporate jets. Dow was chosen for merging business activity with corporate citizenship, resulting in decidedly better prognosis for the thousands of patients who, because of Dow’s generosity, have been able to receive the best possible medical treatment.
Leveraging its corporate aircraft in the interest of humanity is not new to Dow. In early 2010, the Company utilized its aircraft to deliver nearly $1 million of priority medical relief materials to Port-au-Prince, Haiti, in response to the devastating 7.0 magnitude earthquake on January 12. The flight returned with 42 stranded Haitian orphans, from infants to 15 years old, who had been approved for adoption by American families prior to the quake. Dow covered all costs associated with the flight.
In July the same year, Dow flew its third all-expenses paid “Honor Flight,” transporting 75 World War II veterans and Dow retirees, along with 41 Dow employee veterans, from Texas to Washington, D.C. to visit memorials that were built to honor their service to the U.S.
Dow first partnered with Honor Flight in Midland, Mich. in 2007, and again in 2008, and during the two flights collectively escorted more than 150 World War II veteran retirees from Dow and more than 70 Dow employee veterans to Washington.
Dow (NYSE: DOW) combines the power of science and technology to passionately innovate what is essential to human progress. The Company connects chemistry and innovation with the principles of sustainability to help address many of the world's most challenging problems such as the need for clean water, renewable energy generation and conservation, and increasing agricultural productivity. Dow's diversified industry-leading portfolio of specialty chemical, advanced materials, agrosciences and plastics businesses delivers a broad range of technology-based products and solutions to customers in approximately 160 countries and in high growth sectors such as electronics, water, energy, coatings and agriculture. In 2011, Dow had annual sales of $60 billion and employed approximately 52,000 people worldwide. The Company's more than 5,000 products are manufactured at 197 sites in 36 countries across the globe. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at www.dow.com.
For more information, please contact: